about
Unlipidated outer membrane protein Omp16 (U-Omp16) from Brucella spp. as nasal adjuvant induces a Th1 immune response and modulates the Th2 allergic response to cow's milk proteinsBrucella cyclic β-1,2-glucan plays a critical role in the induction of splenomegaly in mice.Brucella abortus induces the secretion of proinflammatory mediators from glial cells leading to astrocyte apoptosisAn oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice.A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c miceVaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infectionOral delivery of Brucella spp. recombinant protein U-Omp16 abrogates the IgE-mediated milk allergyAntibody reactivity to Omp31 from Brucella melitensis in human and animal infections by smooth and rough Brucellae.Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting.Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation usedBrucella abortus induces TNF-α-dependent astroglial MMP-9 secretion through mitogen-activated protein kinasesImmunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infectionU-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in MiceConfronting the barriers to develop novel vaccines against brucellosis.Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells.Diagnostic usefulness of antibodies against ribosome recycling factor from Brucella melitensis in human or canine brucellosis.A bacterial protease inhibitor protects antigens delivered in oral vaccines from digestion while triggering specific mucosal immune responses.Toll-like receptor 6 plays an important role in host innate resistance to Brucella abortus infection in miceSingle-shot plasmid DNA intrasplenic immunization for the production of monoclonal antibodies. Persistent expression of DNA.Brucella abortus Omp19 recombinant protein subcutaneously co-delivered with an antigen enhances antigen-specific T helper 1 memory responses and induces protection against parasite challenge.Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against Brucella canis in BALB/c mice.Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice.Brucella abortus induces intracellular retention of MHC-I molecules in human macrophages down-modulating cytotoxic CD8(+) T cell responses.Brucella lipoproteins mimic dendritic cell maturation induced by Brucella abortus.The vaccine candidate BLSOmp31 protects mice against Brucella canis infection.Brucella abortus activates human neutrophils.RomA, a Periplasmic Protein Involved in the Synthesis of the Lipopolysaccharide Tunes Down the Inflammatory Response Triggered by Brucella.Brucella outer membrane protein Omp31 is a haemin-binding protein.Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovis.The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA.Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4+ and CD8+ T Cells as Well as Systemic and Oral Protection against Brucella abortus Infection.A Brucella spp. Protease Inhibitor Limits Antigen Lysosomal Proteolysis, Increases Cross-Presentation, and Enhances CD8+ T Cell ResponsesBrucella abortus induces apoptosis of human T lymphocytesBrucella abortus inhibits IFN-γ-induced FcγRI expression and FcγRI-restricted phagocytosis via toll-like receptor 2 on human monocytes/macrophagesThe Protein Moiety of Brucella abortus Outer Membrane Protein 16 Is a New Bacterial Pathogen-Associated Molecular Pattern That Activates Dendritic Cells In Vivo, Induces a Th1 Immune Response, and Is a Promising Self-Adjuvanting Vaccine against SysteThe polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in ramsA DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination
P50
Q27311087-2711CBFE-5E74-4A82-87CE-F323926408E8Q31169699-E4C89F5F-E791-4BF0-A008-1BB79BC22621Q33697654-91B9EACF-8CFE-4EEF-A38F-68D6997DAA37Q33802696-42A61352-ECD9-4A58-B2B8-61124E3E3744Q34033400-27A35316-7910-4757-9457-AEA6B21A747CQ34121062-8844BF67-9AB9-41C8-8ED8-6656B76C38A1Q34194709-8DAC49BA-5819-47F2-815E-39F47AAE7CDCQ34291240-B99D4D6D-E8F4-4FD9-B2DC-51F997E4A04FQ35542613-B5ACCFB7-60DB-48A6-86D1-1FB48E774D38Q35946874-E2C4BF98-C72C-434D-94C4-EFEB182B3CBEQ36045879-220B1B71-1176-4AD3-B66F-A9E085F5355EQ36798228-0214E0DF-F659-4293-93D5-F1889878AC34Q37033007-5FB05984-C53F-48FB-AEA6-FA604BA83077Q37647549-9CFAD364-CD89-42D6-8F3D-2ECAA85CD15EQ37932521-229DF97B-5C4E-43D9-A944-B88973EED839Q39320895-E9EF689A-044F-4483-A008-CF460E0D1FFEQ39625589-FD84AF2F-85F2-4258-B0B3-5A2C52F14793Q40443658-18F9C569-95AF-4C27-B0A1-CFD5A805B1FFQ40522881-D1E690B8-4E66-4776-8B76-5655C7AC9E1AQ40848903-5E65E8FF-9222-4735-8980-F51EC496FF80Q40856165-130F34FB-44B3-4CC0-B5B6-8B7BAA4B2315Q41691222-E6940F35-9608-4F62-91C5-843E6D58FDB6Q41911526-EF432BF7-8F7E-4F7B-8EB5-3074346D3952Q42913659-F67F68D4-DB8C-401C-8825-E492CCF2F985Q43624805-20EA38AB-4BC1-4906-9CDF-1FDD39349D80Q44138658-7D0AF646-F7F0-42D1-995E-71CC7C06787EQ47881496-D9FFCE8B-D34B-46A3-BF81-2CF78ED84A04Q47987132-4738FB94-09D7-45D0-9C06-E953F1DB79E2Q50084500-67EA9C81-9C80-43AE-A025-4F041F7496A9Q51253099-0E96D177-515D-40A2-B50A-E79BA3D5D683Q54500942-DC378577-B16E-469B-8193-70B3B74032E6Q54528211-B2A30DE4-C423-48A4-A45C-EBD35FA4CADFQ54550051-214E5923-62EB-4EE2-A942-ECA3878A7D82Q55491931-CA35ED7C-3C13-4322-AA11-0E83E4BF41D3Q58322677-2D787E75-9BA3-4589-A487-A06780857A5FQ58322690-3B9FA274-6DBA-4425-A249-469F4E015F40Q58322693-FF276F8E-C914-4DBA-A2B4-FA8A3746E5BBQ58322694-0073CD63-67C3-48A8-B3F0-E9E6F45F6EB6Q58322698-2550D45A-C7C7-46B1-9CDF-2F77B838AB90Q58322699-5CD7C598-4B5D-48B2-B6B4-BF0EACC7C9F8
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Juliana Cassataro
@ast
Juliana Cassataro
@en
Juliana Cassataro
@es
Juliana Cassataro
@nl
Juliana Cassataro
@sl
type
label
Juliana Cassataro
@ast
Juliana Cassataro
@en
Juliana Cassataro
@es
Juliana Cassataro
@nl
Juliana Cassataro
@sl
prefLabel
Juliana Cassataro
@ast
Juliana Cassataro
@en
Juliana Cassataro
@es
Juliana Cassataro
@nl
Juliana Cassataro
@sl
P106
P1153
55918667200
P21
P2798
P31
P3946
P496
0000-0002-7122-869X